|3.49||0.00 / 0.00%|
As of Oct 21
|3.10||-0.39 / -11.17%|
The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 64.00 and a low estimate of 64.00. The median estimate represents a +1,733.81% increase from the last price of 3.49.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.